0001127602-24-008124.txt : 20240304
0001127602-24-008124.hdr.sgml : 20240304
20240304161913
ACCESSION NUMBER: 0001127602-24-008124
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240229
FILED AS OF DATE: 20240304
DATE AS OF CHANGE: 20240304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: APPIO THOMAS
CENTRAL INDEX KEY: 0001683323
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 24715199
MAIL ADDRESS:
STREET 1: 400 SOMERSET CORPORATE BOULEVARD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-02-29
0000885590
Bausch Health Companies Inc.
BHC
0001683323
APPIO THOMAS
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
NJ
08807
1
1
Chief Executive Officer
0
Common Shares, No Par Value
2024-02-29
4
A
0
519328
0
A
1486338
D
Common Shares, No Par Value
2024-03-01
4
F
0
2895
9.89
D
1483443
D
Common Shares, No Par Value
2024-03-01
4
F
0
2413
9.89
D
1481030
D
Common Shares, No Par Value
2024-03-01
4
F
0
23871
9.89
D
1457159
D
Common Shares, No Par Value
2024-03-01
4
F
0
87803
9.89
D
1369356
D
Represents the award of restricted share units ("RSUs") which will vest one-half on each of the first two anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer ("Common Shares").
This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
/s/ Brianna M. Cetrulo, attorney-in-fact
2024-03-04